Aspira Pathlab P/B Ratio
Aspira Pathlab P/B ratio. Aspira Pathlab (ASPIRA) P/B ratio is 12.22 (High), book value per share ₹12.00 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse ASPIRA financial statements for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ASPIRA P/B Ratio — Valuation Insights & Book Value Analysis
Aspira Pathlab price-to-book ratio interpretation, valuation status and historical context — current P/B 12.22 (High). For live price, earnings yield and the full fundamental profile, see Aspira Pathlab stock price NSE.
- Stock appears overvalued with PB of 12.22, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 113.1% above historical average
- Trading at premium to sector average PB of -0.3
Aspira Pathlab P/B Ratio Historical Trend
ASPIRA annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read Aspira Pathlab dividend policy for the complete payout history and dividend yield track record.
ASPIRA Historical P/B Ratio — Book Value Per Share & Year-End Price
Aspira Pathlab annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 5.52 | ₹12.0 | ₹66.18 | ₹12 | High |
| 2024 | 5.95 | ₹10.0 | ₹59.50 | ₹10 | High |
ASPIRA vs Healthcare Peers — P/B Ratio Comparison
Aspira Pathlab P/B 12.22 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |